ilmscore | 7 Dividend Kings for a Bullet-Proof Portfolio in 2024

Predictions from this Video

Total: 3
Correct: 0
Incorrect: 0
Pending: 3
Prediction
Topic
Status
AbbVie's strong drug pipeline is predicted to sustain its revenue growth.
"The company is a best-in-class pharmaceutical with a strong pipeline across every phase of Trials which is going to keep that Revenue growing."
ABBV
Pending
AbbVie's drugs Skyrizi and Rinvoq are expected to achieve $27 billion in global sales by 2027.
"Skyrizi and Rinvoq both continue their Blockbuster growth expected to reach $27 billion in global sales by 2027 from just 16 billion this year."
ABBV
Pending
Electrical generation utilities, especially those with nuclear capacity or spare capacity, are predicted to see strong returns over the next few years due to increased electricity demand from AI and crypto data centers.
"Wall Street is just realizing the Boom in electricity demand from those data centers tied to Ai and crypto operations so I'd be watching in any electrical generation utility especially nuclear and any with spare capacity to sell for those strong returns over the next few years."
Utilities Sector (Electricity Demand)
Pending